4no2: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of RQA_V phosphopeptide bound to HLA-A2== | ==Crystal structure of RQA_V phosphopeptide bound to HLA-A2== | ||
<StructureSection load='4no2' size='340' side='right' caption='[[4no2]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='4no2' size='340' side='right' caption='[[4no2]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
| Line 6: | Line 7: | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4nnx|4nnx]], [[4nny|4nny]], [[4no0|4no0]], [[4no3|4no3]], [[4no5|4no5]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4nnx|4nnx]], [[4nny|4nny]], [[4no0|4no0]], [[4no3|4no3]], [[4no5|4no5]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4no2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4no2 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4no2 RCSB], [http://www.ebi.ac.uk/pdbsum/4no2 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4no2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4no2 OCA], [http://pdbe.org/4no2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4no2 RCSB], [http://www.ebi.ac.uk/pdbsum/4no2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4no2 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 12: | Line 13: | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/1A02_HUMAN 1A02_HUMAN]] Involved in the presentation of foreign antigens to the immune system. [[http://www.uniprot.org/uniprot/LSP1_HUMAN LSP1_HUMAN]] May play a role in mediating neutrophil activation and chemotaxis (By similarity). [[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. | [[http://www.uniprot.org/uniprot/1A02_HUMAN 1A02_HUMAN]] Involved in the presentation of foreign antigens to the immune system. [[http://www.uniprot.org/uniprot/LSP1_HUMAN LSP1_HUMAN]] May play a role in mediating neutrophil activation and chemotaxis (By similarity). [[http://www.uniprot.org/uniprot/B2MG_HUMAN B2MG_HUMAN]] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. | ||
==See Also== | |||
*[[Beta-2 microglobulin|Beta-2 microglobulin]] | |||
== References == | == References == | ||
<references/> | <references/> | ||